Kazia KZIA 深 沪
已收盘 10-09 16:00:00 美东时间
8.93
+0.110
+1.25%
华盛通- 最 高9.08
- 今 开8.89
- 成交量 12.34万股
- 最 低 8.75
- 昨 收 8.82
- 总市值 1.25亿
- 52周最高 17.40
- 市盈率 静 --
- 换手率 0.88%
- 52周最低 4.86
- 委 比 -43.88%
- 总股本 1400.69万
- 历史最高 744.50
- 量 比 0.70
- 振 幅 3.74%
- 历史最低 3.005
- 每 手 1
- 风险率 2.93%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Kazia Therapeutics Announces Sovargen Doses First Participant In Phase 1b/2a Clinical Study Of Paxalisib To Treat Epilepsies
Kazia Therapeutics Limited (NASDAQ:KZIA), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced that Sovargen Co., Ltd., a biotechnology company specializing in central ...
09-22 19:33
美股大行评级 | 齐声看好医药股！礼来、强生、默沙东目标价均获上调；小摩大幅上调Meta目标价至820美元
今日重点评级关注：康托·菲茨杰拉德：维持SOL Strategies"超配"评级，目标价从2.8美元升至6.2美元；康托·菲茨杰拉德：维持Sui Group Holdings"超配"评级，目标价从1.7美元升至3.4美元
09-11 14:30
Kazia Therapeutics Doses First Participant In Its Arm A Of PNOC035 Platform To Evaluate Paxalisib In Combination With Gemcitabine Toi Treat Atypical Teratoid/Rhabdoid Tumor
Kazia Therapeutics Limited (NASDAQ:KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced that the first patient has been dosed in Arm A...
09-09 19:32
美股大行评级 | 美银上调微软目标价从500美元升至600美元；BlossomHill获小摩等多家大行首予买入评级
今日重点评级关注：BTIG：维持Kazia Therapeutics"买入"评级，目标价从34美元升至40美元；摩根大通：维持Annexon"超配"评级，目标价从10美元升至14美元
09-02 14:07
BTIG Maintains Buy on Kazia Therapeutics, Raises Price Target to $40
BTIG analyst Kambiz Yazdi maintains Kazia Therapeutics (NASDAQ:KZIA) with a Buy and raises the price target from $34 to $40.
09-01 22:56
Kazia Therapeutics Unveils New Investor-Focused Website
Kazia Therapeutics ( ($KZIA) ) has shared an announcement. On August 28, 2026, ...
08-31 19:57
Pre-Bell Movers | WHLR Rises by 125.9%; Here Are 20 Stocks Moving Premarket (Aug 28)
US stock futures mixed as markets await Fed Chair Warsh’s Jackson Hole speech, with big moves in premarket trading driven by earnings, guidance, and M&A news.
08-28 16:29
美股牛股 | 软件股集体爆发！多家公司上调全年指引，Okta暴升28.6%，赛富时狂飙22.6%，CrowdStrike劲升20.5%
软件股集体爆发！Okta暴涨28.6%，赛富时飙升22.6%，CrowdStrike劲升20.5%。财报季利好密集释放，多家公司业绩超预期并上调全年指引>>
08-28 11:28
Kazia Therapeutics shares are trading lower after the company announced a proposed public offering.
Kazia Therapeutics shares are trading lower after the company announced a proposed public offering.
08-28 04:18
Kazia Therapeutics Commences Offering Of American Depositary Shares; Terms Undisclosed
Kazia Therapeutics Limited (NASDAQ:KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced that it has commenced a tranched registered pu...
08-28 04:13
